Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Cash from Operations (2016 - 2021)

Historic Cash from Operations for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$2.7 million.

  • ENDRA Life Sciences' Cash from Operations fell 2795.9% to -$2.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.1 million, marking a year-over-year decrease of 349.68%. This contributed to the annual value of -$7.4 million for FY2024, which is 2249.74% up from last year.
  • As of Q4 2021, ENDRA Life Sciences' Cash from Operations stood at -$2.7 million, which was down 2795.9% from -$2.7 million recorded in Q3 2021.
  • ENDRA Life Sciences' 5-year Cash from Operations high stood at -$236274.0 for Q1 2017, and its period low was -$3.5 million during Q2 2020.
  • Its 5-year average for Cash from Operations is -$2.1 million, with a median of -$2.1 million in 2020.
  • Its Cash from Operations has fluctuated over the past 5 years, first crashed by 93773.16% in 2018, then surged by 1889.68% in 2021.
  • ENDRA Life Sciences' Cash from Operations (Quarter) stood at -$1.4 million in 2017, then plummeted by 38.3% to -$1.9 million in 2018, then dropped by 0.27% to -$1.9 million in 2019, then dropped by 8.68% to -$2.1 million in 2020, then fell by 27.96% to -$2.7 million in 2021.
  • Its last three reported values are -$2.7 million in Q4 2021, -$2.7 million for Q3 2021, and -$2.8 million during Q2 2021.